MXPA03001607A - Nuevos macrolidos con actividad antibacteriana. - Google Patents

Nuevos macrolidos con actividad antibacteriana.

Info

Publication number
MXPA03001607A
MXPA03001607A MXPA03001607A MXPA03001607A MXPA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A
Authority
MX
Mexico
Prior art keywords
antibacterial activity
new macrolides
heterocyclyl
hydrogen
formula
Prior art date
Application number
MXPA03001607A
Other languages
English (en)
Spanish (es)
Inventor
Peter Angehrn
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of MXPA03001607A publication Critical patent/MXPA03001607A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MXPA03001607A 2000-08-22 2001-08-20 Nuevos macrolidos con actividad antibacteriana. MXPA03001607A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00117971 2000-08-22
PCT/EP2001/009560 WO2002016380A1 (en) 2000-08-22 2001-08-20 New macrolides with antibacterial activity

Publications (1)

Publication Number Publication Date
MXPA03001607A true MXPA03001607A (es) 2003-06-04

Family

ID=8169600

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001607A MXPA03001607A (es) 2000-08-22 2001-08-20 Nuevos macrolidos con actividad antibacteriana.

Country Status (14)

Country Link
US (1) US6740642B2 (https=)
EP (1) EP1313751B1 (https=)
JP (1) JP4162992B2 (https=)
KR (1) KR100502031B1 (https=)
CN (1) CN1234718C (https=)
AT (1) ATE408614T1 (https=)
AU (1) AU2001282105A1 (https=)
BR (1) BR0113472A (https=)
CA (1) CA2419296C (https=)
DE (1) DE60135859D1 (https=)
ES (1) ES2313975T3 (https=)
MX (1) MXPA03001607A (https=)
WO (1) WO2002016380A1 (https=)
ZA (1) ZA200301047B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077557A1 (en) * 2000-12-21 2004-04-22 Sulejman Ali Macrolide antibiotics
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
WO2003024986A1 (en) * 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
US6716820B1 (en) 2003-06-05 2004-04-06 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic macrolides
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
WO2004108745A2 (en) * 2003-06-05 2004-12-16 Enanta Pharmaceuticals, Inc. 11-12 bicyclic erythromycin derivatives
US6765016B1 (en) 2003-06-05 2004-07-20 Enanta Pharmaceuticals, Inc. Bicyclic ketolide derivatives
US6790835B1 (en) 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US6774115B1 (en) 2003-06-05 2004-08-10 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic ketolides
WO2006065721A2 (en) * 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
JP5112079B2 (ja) 2005-02-09 2013-01-09 バジリア ファルマスーチカ アーゲー 新規なマクロライド
CN101115764B (zh) * 2005-02-09 2012-09-26 巴斯利尔药物股份公司 大环内酯类化合物
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
EP3290427A1 (en) 2005-08-24 2018-03-07 Melinta Therapeutics, Inc. Triazole compounds and methods of making and using the same
BRPI0716408A2 (pt) * 2006-08-09 2013-09-24 Basilea Pharmaceutica Ag macrolÍdeos éteis doenÇa inflamatària e alÉrgica
CA2661538A1 (en) * 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
CA2714389C (en) * 2008-02-08 2016-10-18 Basilea Pharmaceutica Ag Macrolides and uses of macrolides
WO2009106419A1 (en) * 2008-02-08 2009-09-03 Basilea Pharmaceutica Ag New macrolides and their use
ES2561332T3 (es) 2009-05-27 2016-02-25 Wockhardt Limited Compuestos cetólidos que tienen actividad antimicrobiana
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
CN102417530A (zh) * 2010-09-26 2012-04-18 中国医学科学院药物研究所 广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途
PT2673285T (pt) 2010-12-09 2017-10-19 Wockhardt Ltd Resumo
JP5718488B2 (ja) 2011-03-01 2015-05-13 ウォックハート リミテッド ケトライド中間体の調製方法
HUE030196T2 (en) * 2012-12-31 2017-04-28 Basilea Pharmaceutica Ag Macrolides with PDE4 inhibitory activity
AU2017206672A1 (en) 2016-01-12 2018-08-23 Wockhardt Limited Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
ZA200301047B (en) 2004-05-06
US6740642B2 (en) 2004-05-25
JP2004506740A (ja) 2004-03-04
ES2313975T3 (es) 2009-03-16
US20030199459A1 (en) 2003-10-23
JP4162992B2 (ja) 2008-10-08
BR0113472A (pt) 2003-07-01
EP1313751A1 (en) 2003-05-28
KR20030029839A (ko) 2003-04-16
CN1234718C (zh) 2006-01-04
KR100502031B1 (ko) 2005-07-25
AU2001282105A1 (en) 2002-03-04
WO2002016380A1 (en) 2002-02-28
CA2419296C (en) 2008-12-09
CA2419296A1 (en) 2002-02-28
EP1313751B1 (en) 2008-09-17
CN1464880A (zh) 2003-12-31
DE60135859D1 (de) 2008-10-30
ATE408614T1 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
MXPA03001607A (es) Nuevos macrolidos con actividad antibacteriana.
HK1046688A1 (zh) 喹唑啉化合物和含有喹唑啉化合物的藥物組合物
FR2742757B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CA2284732A1 (en) Analogs of cocaine
MY146279A (en) Compounds affecting glucokinase
ATE541576T2 (de) 2'-o,4'-c-methylen bicyclonukleoside
EP1036794A4 (en) 2-ARYL-8-OXODIHYDROPURIN DERIVATIVES, THEIR PRODUCTION, THEIR USE AS MEDICINE COMPONENTS AND THEIR INTERMEDIATES
CA2469813A1 (en) Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
CA2476884A1 (en) Macrolides with antibacterial activity
YU50002A (sh) Supstituisani piperidini, lekovi koji sadrže ova jedinjenja i postupci za njihovu proizvodnju
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
NO991700L (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
AU2001295482A1 (en) Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
PL350651A1 (en) 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
TR199801753T2 (xx) Pirimido(5,4-D) pirimidin bile�imini i�eren ila�lar, kullan�mlar� ve �retim i�lemleri.
EP1153924A3 (en) Substituted 1,3-oxathiolanes with antiviral properties
MY123310A (en) Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
WO2004108664A3 (de) Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
DE69907419D1 (en) Antitumorwirkstoffe
MXPA03011682A (es) Derivados sustituidos de n-acil -anilina, su preparacion y su uso como medicamento.
WO1999004770A3 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
WO2006034822A8 (de) Neue substituierte thiophencarbonsäureamide, deren herstellung und deren verwendung als arzneimittel
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
EP0497978A4 (en) Cephalosporin compounds and production thereof

Legal Events

Date Code Title Description
FG Grant or registration